EUVIMEDOpdag EUVIMED
Fallbericht

A nuclear beacon of hope: an advanced, metastatic glucagonoma treated with [177Lu]Lu-DOTA-TATE

Martyna Kłosińska iD, Joanna Kołodziej iD, Adrianna Mróz iD, Weronika Mądra iD, Grzegorz Kamiński iD

Nuclear Medicine Review · 2024

DOI: 10.5603/nmr.101985 ↗

At a glance

Fallbericht in Nuclear Medicine Review, 2024. Written by Martyna Kłosińska and 4 co-authors. Institution: Department of Endocrinology and Radioisotope Therapy, Military Institute of Medicine - National Research Institute, Warsaw, Poland. Major MEDLINE topics: Glucagonoma, Organometallic Compounds, Octreotide, Pancreatic Neoplasms. Cited 2 times so far (Crossref).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Glucagonoma is a rare pancreatic neuroendocrine tumor (panNET) that can be characterized by increased secretion of glucagon and distinguishing symptoms — glucagonoma syndrome with a typical dermatosis, necrolytic migratory erythema, being its most common manifestation. While surgery and somatostatin analogs remain first-line therapeutic options in panNETs, radioligand therapy with [177Lu]Lu-DOTA-TATE is a recommended second-line palliative treatment in advanced, metastatic cases. However, its prospects and efficacy are still not vastly researched in less frequent neuroendocrine neoplasms. Here, we present an extraordinary case of a metastatic glucagonoma treated with [177Lu]Lu-DOTA-TATE used as a second-line treatment in progressive disease.

Subjects

MeSH terms (MEDLINE)

GlucagonomaOrganometallic CompoundsOctreotidePancreatic NeoplasmsHumansNeoplasm MetastasisMaleMiddle Aged

Author keywords

[177Lu]Lu-DOTA-TATEglucagonomalutetiumnecrolytic migratory erythemapancreatic neuroendocrine tumorradioligand therapy

Substances

Organometallic CompoundsOctreotidelutetium Lu 177 dotatate

Authors and institutions

  • Department of Endocrinology and Radioisotope Therapy, Military Institute of Medicine - National Research Institute, Warsaw, Poland.
  • Department of Endocrinology and Radioisotope Therapy, Military Institute of Medicine - National Research Institute, Warsaw, Poland. jkolodziej1@wim.mil.pl.

ORCID profiles: Martyna Kłosińska, Joanna Kołodziej, Adrianna Mróz, Weronika Mądra, Grzegorz Kamiński

Cite

APA

Kłosińska, M., Kołodziej, J., Mróz, A., Mądra, W., & Kamiński, G. (2024). A nuclear beacon of hope: an advanced, metastatic glucagonoma treated with [177Lu]Lu-DOTA-TATE. Nuclear Medicine Review. https://doi.org/10.5603/nmr.101985

Vancouver

Kłosińska M, Kołodziej J, Mróz A, Mądra W, Kamiński G. A nuclear beacon of hope: an advanced, metastatic glucagonoma treated with [177Lu]Lu-DOTA-TATE. Nuclear Medicine Review. 2024. doi:10.5603/nmr.101985

BibTeX
@article{Kosiska2024,
  author = {Kłosińska, Martyna and Kołodziej, Joanna and Mróz, Adrianna and Mądra, Weronika and Kamiński, Grzegorz},
  title = {A nuclear beacon of hope: an advanced, metastatic glucagonoma treated with [177Lu]Lu-DOTA-TATE},
  journal = {Nuclear Medicine Review},
  year = {2024},
  doi = {10.5603/nmr.101985}
}
Start for free →